Parainfluenza Virus Infection Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight

DelveInsight's "Parainfluenza Virus Infection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Parainfluenza Virus Infection, historical and forecasted epidemiology as well as the Parainfluenza Virus Infection market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Parainfluenza Virus Infection market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Parainfluenza Virus Infection Market Forecast- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from Parainfluenza Virus Infection Market Report
• In June 2025, Pulmotect Inc. announced study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity of lung infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation with documented viral infections due to PIV, hMPV, or RSV. PUL-042 or a placebo will be administered 3 times over a 6-day period. The total duration of the study will be approximately 30 days.
• According to DelveInsight estimations, 2,709,923 Cases of Parainfluenza virus infection were found in 2023 in the 7MM.
• As per DelveInsight's estimations, the total number of Parainfluenza Virus Infection Incident Cases in the United States were 1,456,399 in 2023 and are projected to increase during the forecast period.
• According to DelveInsight's estimates, the total Parainfluenza Virus Infection Incident Cases in EU4 and the UK were found to be 991,115 in 2023. The highest proportion of parainfluenza virus infection cases was reported in Spain among the EU4 countries, while the least number of cases was found in the UK.
• The estimates show the number of parainfluenza virus infection cases in Japan was found to be approximately 262,409 in 2023, which is estimated to increase by 2034.
• The leading Parainfluenza Virus Infection Companies such as Ansun Biopharma, AlloVir, MedImmune LLC, and others.
• Promising Parainfluenza Virus Infection Therapies such as DAS181, ALVR106, Oplunofusp, MEDI-534, and others.

Stay ahead in the Parainfluenza Virus Infection Therapeutics Market with DelveInsight's Strategic Report @ Parainfluenza Virus Infection Market Outlook- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Parainfluenza Virus Infection Epidemiology Segmentation:
The Parainfluenza Virus Infection market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Parainfluenza Virus Infection
• Prevalent Cases of Parainfluenza Virus Infection by severity
• Gender-specific Prevalence of Parainfluenza Virus Infection
• Diagnosed Cases of Episodic and Chronic Parainfluenza Virus Infection

Download the report to understand which factors are driving Parainfluenza Virus Infection epidemiology trends @ Parainfluenza Virus Infection Prevalence- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Parainfluenza Virus Infection Emerging Drugs
• DAS181: Ansun Biopharma
DAS181 is a first-in-class recombinant sialidase protein that is designed to remove sialic acids located on the surface of epithelial cells lining the human respiratory tract. These sialic acids are naturally present on cell surfaces and are needed by some viruses for viral entry into cells. Cleavage of sialic acid inactivates the mechanism for viral entry and infection, interrupting the virus lifecycle and giving patients the chance to recover. DAS181 has demonstrated antiviral activity against three of the four major respiratory viruses, influenza virus (IFV), parainfluenza virus (PIV), and metapneumovirus (MPV), as well as human enterovirus-68 (EV-68).

• ALVR106: AlloVir
ALVR106 is an allogeneic, off-the-shelf, multivirus-specific VST investigational therapy designed to target infections and diseases caused by the respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV), and human metapneumovirus (hMPV). In vitro data demonstrate that ALVR106 has antiviral activity against each of the targeted viruses with minimal or no activity against non-virus-infected cells. (AlloVir, 2024). It is being developed in Phase I/II of clinical trials as per the company's pipeline; however, the trial evaluating it was terminated before its completion as part of a strategic sponsor decision. The preclinical data of ALVR106 supports the potential for antiviral benefit and safety of ALVR106 when administered to patients.

Parainfluenza Virus Infection Market Outlook
Presently, the primary approach to treating Parainfluenza Virus Infection involves supportive care, except for croup, where corticosteroids have been identified as beneficial. Novel Parainfluenza Virus Infection Drugs like DAS181 show promise for treating severe cases in immunocompromised patients and are currently undergoing development. Despite continuous endeavors, effective treatment options for Parainfluenza Virus Infection remain lacking, with no approved medications addressing this critical gap in care. Specifically, there is still no FDA-approved cure or antiviral medication designated for treating Parainfluenza Virus Infection.

Parainfluenza Virus Infection Therapies and Key Companies
• DAS181: Ansun Biopharma
• ALVR106: AlloVir
• Oplunofusp: Ansun Biopharma
• MEDI-534: MedImmune LLC

Discover more about therapies set to grab major Parainfluenza Virus Infection market share @ Parainfluenza Virus Infection Treatment Landscape- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Parainfluenza Virus Infection Market Drivers
• Rising Incidence
• Advancements in Diagnostic Tools
• Growing Awareness
• Development of Vaccines
• Supportive Healthcare Policies

Parainfluenza Virus Infection Market Barriers
• Lack of Specific Treatments
• High R&D Costs
• Limited Awareness in Low-Income Regions
• Seasonal Variability
• Regulatory Challenges

Get In-Depth Knowledge on Parainfluenza Virus Infection Market Trends and Forecasts with DelveInsight @ Parainfluenza Virus Infection Treatment Market- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Parainfluenza Virus Infection Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Parainfluenza Virus Infection Companies: Ansun Biopharma, AlloVir, MedImmune LLC, and others
• Parainfluenza Virus Infection Therapies: DAS181, ALVR106, Oplunofusp, MEDI-534, and others
• Parainfluenza Virus Infection Therapeutic Assessment: Parainfluenza Virus Infection current marketed and Parainfluenza Virus Infection emerging therapies
• Parainfluenza Virus Infection Market Dynamics: Parainfluenza Virus Infection market drivers and Parainfluenza Virus Infection market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Parainfluenza Virus Infection Unmet Needs, KOL's views, Analyst's views, Parainfluenza Virus Infection Market Access and Reimbursement

To know more about Parainfluenza Virus Infection companies working in the treatment market, visit @ Parainfluenza Virus Infection Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Parainfluenza Virus Infection Market Report Introduction
2. Executive Summary for Parainfluenza Virus Infection
3. SWOT analysis of Parainfluenza Virus Infection
4. Parainfluenza Virus Infection Patient Share (%) Overview at a Glance
5. Parainfluenza Virus Infection Market Overview at a Glance
6. Parainfluenza Virus Infection Disease Background and Overview
7. Parainfluenza Virus Infection Epidemiology and Patient Population
8. Country-Specific Patient Population of Parainfluenza Virus Infection
9. Parainfluenza Virus Infection Current Treatment and Medical Practices
10. Parainfluenza Virus Infection Unmet Needs
11. Parainfluenza Virus Infection Emerging Therapies
12. Parainfluenza Virus Infection Market Outlook
13. Country-Wise Parainfluenza Virus Infection Market Analysis (2020-2034)
14. Parainfluenza Virus Infection Market Access and Reimbursement of Therapies
15. Parainfluenza Virus Infection Market Drivers
16. Parainfluenza Virus Infection Market Barriers
17. Parainfluenza Virus Infection Appendix
18. Parainfluenza Virus Infection Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

List of Top Selling Market Research Reports in 2025

radial artery compression device market- https://www.delveinsight.com/report-store/transradial-access-products-market
vital sign monitors devices market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
cone rod dystrophy market- https://www.delveinsight.com/report-store/cone-rod-dystrophy-market
opioid-related disorders market- https://www.delveinsight.com/report-store/opioid-related-disorders-market
adeno associated viruses aav gene therapy market- https://www.delveinsight.com/report-store/adeno-associated-virus-aav-vectors-in-gene-therapy-pipeline-insight
cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
scoliosis market - https://www.delveinsight.com/report-store/scoliosis-market
antibody drug conjugate market - https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
methicillin-resistant staphylococcus aureus infection market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
pediatric brain tumor market- https://www.delveinsight.com/report-store/pediatric-brain-tumors-market
smoking cessation market- https://www.delveinsight.com/report-store/smoking-cessation-and-nicotine-addiction-market
uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
atopic dermatitis market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
cardiogenic shock market- https://www.delveinsight.com/report-store/early-cardiogenic-shock-cs-market
chemotherapy induced neutropenia market- https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
CXCR inhibitors market- https://www.delveinsight.com/report-store/selective-inhibitor-of-the-cxcr4-chemokine-receptor-market-forecast
friedreich's ataxia market- https://www.delveinsight.com/report-store/friedreichs-ataxia-market
herpes labialis market- https://www.delveinsight.com/report-store/herpes-labialis-market
herpes zoster market- https://www.delveinsight.com/report-store/herpes-zoster-market
somatotropin deficiency market- https://www.delveinsight.com/report-store/growth-hormone-deficiency-ghd-market
spinal trauma devices market- https://www.delveinsight.com/report-store/trauma-devices-market
tcr therapy market- https://www.delveinsight.com/report-store/tcr-therapy-market
transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
atherosclerosis market- https://www.delveinsight.com/report-store/atherosclerotic-cardiovascular-disease-ascvd-market
carcinoid syndrome market- https://www.delveinsight.com/report-store/carcinoid-tumor-market
cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
chronic heart failure market- https://www.delveinsight.com/report-store/heart-failure-market
chronic venous ulceration market- https://www.delveinsight.com/report-store/chronic-venous-ulceration-market
diabetic wound market- https://www.delveinsight.com/report-store/diabetic-wounds-market
hypertrophic cardiomyopathy market- https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-market
langerhans cell histiocytosis market- https://www.delveinsight.com/report-store/langerhans-cell-histiocytosis-market
liver fibrosis market- https://www.delveinsight.com/report-store/liver-fibrosis-market
membranous nephropathy market- https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-imn-market
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
pelvic organ prolapse market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
plaque modification devices market- https://www.delveinsight.com/report-store/plaque-modification-devices-market
primary ciliary dyskinesia market- https://www.delveinsight.com/report-store/primary-ciliary-dyskinesia-market
psoriasis vulgaris market- https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
radiodermatitis market- https://www.delveinsight.com/report-store/radiation-dermatitis-market
ranibizumab biosimilars market- https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
seasonal allergic rhinitis market- https://www.delveinsight.com/report-store/allergic-rhinitis-market
sly syndrome market- https://www.delveinsight.com/report-store/sly-syndrome-market
social anxiety disorder market- https://www.delveinsight.com/report-store/social-anxiety-disorder-market
soft tissue sarcoma with lung metastasis market- https://www.delveinsight.com/report-store/soft-tissue-sarcoma-with-lung-metastases-market
surgical bleeding market- https://www.delveinsight.com/report-store/surgical-bleeding-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.